Price Don’t Lie: Core Laboratories N.V. Stock Price Increases Today

Price Don't Lie: Core Laboratories N.V. Stock Price Increases Today

The stock of Core Laboratories N.V. (NYSE:CLB) is a huge mover today! About 338,195 shares traded hands. Core Laboratories N.V. (NYSE:CLB) has declined 20.77% since April 27, 2016 and is downtrending. It has underperformed by 25.99% the S&P500.
The move comes after 5 months positive chart setup for the $4.89B company. It was reported on Nov, 30 by Barchart.com. We have $121.04 PT which if reached, will make NYSE:CLB worth $391.20 million more.

Analysts await Core Laboratories N.V. (NYSE:CLB) to report earnings on January, 25. They expect $0.40 EPS, down 38.46% or $0.25 from last year’s $0.65 per share. CLB’s profit will be $17.45M for 70.04 P/E if the $0.40 EPS becomes a reality. After $0.38 actual EPS reported by Core Laboratories N.V. for the previous quarter, Wall Street now forecasts 5.26% EPS growth.

Core Laboratories N.V. (NYSE:CLB) Ratings Coverage

Out of 15 analysts covering Core Laboratories (NYSE:CLB), 8 rate it a “Buy”, 0 “Sell”, while 7 “Hold”. This means 53% are positive. Core Laboratories has been the topic of 27 analyst reports since August 24, 2015 according to StockzIntelligence Inc. RBC Capital Markets upgraded the stock to “Outperform” rating in Friday, September 18 report. On Thursday, January 28 the stock rating was maintained by RBC Capital Markets with “Outperform”. As per Thursday, October 6, the company rating was initiated by DA Davidson. The rating was initiated by Stephens on Tuesday, April 5 with “Equal-Weight”. The company was maintained on Wednesday, September 28 by Citigroup. The rating was maintained by Howard Weil with “Sector Perform” on Friday, January 29. Morgan Stanley maintained the shares of CLB in a report on Tuesday, April 19 with “Overweight” rating. On Thursday, September 1 the stock rating was initiated by Credit Suisse with “Neutral”. The firm has “Neutral” rating by Citigroup given on Friday, March 18. The firm has “Neutral” rating by Citigroup given on Monday, May 16.

According to Zacks Investment Research, “Based in the Netherlands, Core Laboratories provides geological and environmental analysis services and manufactures precise measurement equipment. The company provides basic and advanced reservoir rock and fluid analyses and other geological services to the oil industry. It provides information that helps oil companies make decisions regarding the presence and amount of hydrocarbon accumulations. The company’s manufacturing operations include the design and production of laboratory equipment used in the petroleum industry.”

Insitutional Activity: The institutional sentiment increased to 1.13 in Q2 2016. Its up 0.04, from 1.09 in 2016Q1. The ratio is positive, as 37 funds sold all Core Laboratories N.V. shares owned while 118 reduced positions. 53 funds bought stakes while 116 increased positions. They now own 43.11 million shares or 0.25% more from 43.00 million shares in 2016Q1.
Moreover, Telemus Limited Liability Company has 0.23% invested in Core Laboratories N.V. (NYSE:CLB) for 14,979 shares. Zurcher Kantonalbank (Zurich Cantonalbank) last reported 14,487 shares in the company. Ci Glob Invests Inc holds 0.02% or 7,000 shares in its portfolio. The Minnesota-based Ameriprise Financial has invested 0% in Core Laboratories N.V. (NYSE:CLB). Bailard holds 3,048 shares or 0.05% of its portfolio. Bokf Na last reported 3,703 shares in the company. Academy Mgmt Tx holds 69,389 shares or 2.21% of its portfolio. Tower Capital Limited Liability Corp (Trc) has 1,723 shares for 0.02% of their US portfolio. First Manhattan reported 285 shares or 0% of all its holdings. Marble Harbor Investment Counsel Ltd Limited Liability Company last reported 0.2% of its portfolio in the stock. Trustmark Bancorporation Tru Department owns 1,631 shares or 0.03% of their US portfolio. Moreover, Shinko Asset Mngmt has 0% invested in Core Laboratories N.V. (NYSE:CLB) for 136 shares. Amp Capital Investors Limited last reported 0.02% of its portfolio in the stock. Cadence Bancshares Na accumulated 0.18% or 2,890 shares. Biondo Invest Advisors Llc reported 42,757 shares or 1.89% of all its holdings.

More notable recent Core Laboratories N.V. (NYSE:CLB) news were published by: Fool.com which released: “Core Laboratories NV’s Earnings Sparked a 13% Slide in October, Should …” on November 08, 2016, also Fool.com with their article: “Core Laboratories NV Earnings Bottom Out” published on July 21, 2016, Fool.com published: “What’s Core Laboratories N.V. Doing to Outperform Its Oil-Service Peers?” on November 08, 2015. More interesting news about Core Laboratories N.V. (NYSE:CLB) were released by: Seekingalpha.com and their article: “Core Laboratories NV (CLB) CEO David Demshur on Q3 2016 Results – Earnings …” published on October 20, 2016 as well as Prnewswire.com‘s news article titled: “Core Lab Reports Q3 2016 Results:” with publication date: October 19, 2016.

CLB Company Profile

Core Laboratories N.V., incorporated on July 8, 1994, is a well-known provider of reservoir description, production enhancement and reservoir management services to the gas and oil industry. The Company’s services and products are directed toward enabling the Company’s clients to improve reservoir performance and increase gas and oil recovery from their producing fields. The Firm has over 70 offices in over 50 countries. The Firm operates in three divisions: Reservoir Description, Production Enhancement and Reservoir Management. These divisions provide different services and products and utilize different technologies for improving reservoir performance, and increasing gas and oil recovery from new and existing fields. The Firm offers its services through its global network of offices. The Firm makes products primarily in over four facilities for distribution on a global basis.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment